Skip to main content
OpenTrials
Completed

NCT Number: NCT05701878

COVID-19 Self-testing Study

The goal of this clinical trial is to understand how the introduction of an app-based intervention changes knowledge, attitudes, and practices on COVID-19 self-testing.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ICAP Harlem Prevention Center

New York, 10027, United States

About this study

Rapid diagnostic testing has been shown to be an important tool in controlling the spread of the COVID-19 pandemic by identifying people when they are likely to be most contagious and reducing crowding at testing sites. In addition to employer-mandated testing, rapid antigen tests are becoming increasingly used by individuals. A method to promote frequent self-testing would help break the chain of viral transmission, slow the spread of disease, slow the spread of vaccine-resistant variants, and improve pandemic management.

The ubiquity of smartphones along with their data connectivity capabilities and onboard sensors make them an attractive tool to complement rapid diagnostic tests and an important component of decentralized testing. Smartphone-based tools have shown high acceptability among healthcare workers for the real-time tracking of rapid test results.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • English-speaking
  • 18 years old or older
  • Owns a smartphone running either Android or iOS operating systems
  • Willing to download a COVID-19 self-testing app
  • Willing to receive and send text messages for the study (and fill out surveys linked from text messages)

Exclusion criteria

  • Not willing to self-test themselves with COVID-19 rapid tests

Treatment and study plan

SMARTest mobile app for COVID-19 self-testing

Behavioral

The mobile app has self-testing features and information with regard to self-testing and COVID-19.

Primary outcomes

  1. COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study initiation

    Time frame: Baseline

    COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.

  2. COVID-19 Self-Testing Knowledge, Attitudes, and Practices Questionnaire Score - study completion

    Time frame: At study completion (About 1 month after enrollment)

    COVID-19 Rapid Tests Knowledge, Attitudes, and Practices Questionnaire is a self-assessment measuring participant attitudes, knowledge, and practices toward COVID-19 rapid tests and self-testing.

Sponsors and collaborators

Lead sponsor

Columbia University

Other

Registry information

Official study title

Field Test of COVID-19 Self-testing With Rapid Antigen Tests

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jan 27, 2023
Registry last updated
Feb 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.